Enhanced anti-tumor responses induced by the combination of a couple of stimulators: IL-12 and CCL27

被引：0
|
作者：
Sugita, T
Gao, JQ
Kanagawa, N
Motomura, Y
Nakayama, T
Yoshie, O
Hatanaka, Y
Tani, Y
Mizuguchi, H
Tsutsumi, Y
Nakagawa, S
机构：
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan
[2] Kinki Univ, Sch Med, Dept Microbiol, Osaka 589, Japan
[3] DakoCytomat Co Ltd, Dept Biomed Sci, Kyoto, Japan
[4] Natl Inst Biomed Innovat, Osaka, Japan
来源：
JOURNAL OF GENE MEDICINE | 2006年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [41] The increasingly anti-tumor effect of a colonic carcinoma DNA vaccine carrying HER2 by the adjuvanticity of IL-12
    Gao, Ping
    Zhang, Chunhua
    Bian, Xiaoxia
    Guo, Yanjun
    Wei, Yueguang
    Zhang, Li
    Liu, Zhaoyang
    Wang, Xiuying
    Huang, Shumin
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (06) : 441 - 446
  • [42] IL-12 expression in nasophazyngeal carcinoma tissues induces nitric oxide release but fail to induce anti-tumor activity
    Bourouba, M.
    Zergoun, A. -A.
    Elhadjan, M.
    Asselah, F.
    Djenaoui, D.
    Touil-Boukoffa, C.
    CYTOKINE, 2012, 59 (03) : 538 - 538
  • [43] Cytokines in the IL-12 Family Distinctly Impact the Functional Fate and Anti-Tumor Activity of TC17 Cells
    Kundimi, Sreenath
    Nelson, Michelle H.
    Huff, Logan W.
    Rogers, Carolyn E.
    Paulos, Chrystal M.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 725 - 725
  • [44] INTRATUMORAL ADMINISTRATION AND LOCAL RETENTION OF IL-2/IL-12 FUSION PROTEINS DRIVE A POTENT SYSTEMIC ANTI-TUMOR IMMUNE RESPONSE
    Naveen, Mehta
    Li, Bochong
    Wittrup, Dane
    Baeuerle, Patrick
    Michaelson, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A918 - A918
  • [45] CLN-617 IS AN INTRATUMORALLY INJECTED AND LOCALLY RETAINED FUSION OF IL-2 AND IL-12 THAT DRIVES SYSTEMIC ANTI-TUMOR ACTIVITY
    Naveen, Mehta
    Rakhra, Kavya
    Meetze, Kristan
    Shapiro, Irina
    Wittrup, Karl
    Baeuerle, Patrick
    Michaelson, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1103 - A1103
  • [46] Tumor-infiltrating lymphocytes with inducible membrane-tethered IL-12 cultured in optimized media exhibits superior anti-tumor activity
    Innamarato, P.
    Gilbert, N. J.
    Pulido, A. de Mingo
    Alkhouli, M.
    Fang, J.
    Sapena, G.
    Hall, S.
    Yin, H.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S695 - S695
  • [47] Conditionally Activated IL-12 or IFNα IndukineTM Molecules Inhibit Syngeneic Lymphoma Tumor Growth in Mice, Induce Anti-Tumor Immune Responses and Are Tolerated in Non-Human Primates
    Steiner, Philipp
    Brodkin, Heather
    Canales, Josue
    Hicklin, Daniel
    Isaacs, Randi
    Ismail, Nesreen
    Morris, Kristin
    Nirschl, Christopher
    Salmeron, Andres
    Seidel-Dugan, Cindy
    Steuert, Zoe
    Sullivan, Jenna
    Tyagi, Ethika
    Winston, William
    BLOOD, 2021, 138
  • [48] Retroviral-mediated gene transfer of murine IL-12 into tumor cells and fibroblasts as a strategy to increase the host anti-tumor immune system
    Govaerts, AS
    Andre, M
    Guillaume, T
    Bayat, B
    Feyens, AM
    Symann, M
    CANCER GENE THERAPY, 1996, 3 (06) : P24 - P24
  • [49] ANCHORED IMMUNOTHERAPY WITH INTRATUMORALLY ADMINISTERED ALUMINUM HYDROXIDE-TETHERED IL-12 INDUCES POTENT ANTI-TUMOR IMMUNE RESPONSE
    Battula, Sailaja
    Papastoitsis, Gregory
    Kaufman, Howard
    Wittrup, K.
    Schmidt, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1118 - A1118
  • [50] CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?
    Gumperz, JE
    JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (02) : 307 - 313
12345